Status:
COMPLETED
Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
Lead Sponsor:
University of Skopje
Collaborating Sponsors:
Ministry of Science and Education, R. Macedonia
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18-65 years
Brief Summary
Patients treated by chronic renal replacement therapy are exposed to cardiovascular problems and suffer from an accelerated and sever atherosclerosis. Classical risk factors for atherosclerosis and ca...
Detailed Description
Rationale: Patients treated by chronic renal replacement therapy are exposed to cardiovascular problems and suffer from an accelerated and sever atherosclerosis. Classical risk factors for atheroscler...
Eligibility Criteria
Inclusion
- Chronic renal failure patients with a need for creation of AV fistula
- Dialysis patients with a need of reanastomosing of the AV fistula (thrombosis or insufficient blood flow)
Exclusion
- Diabetes
- Malignant disease
- Prior treatment with corticosteroids
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00412139
Start Date
December 1 2006
End Date
January 1 2010
Last Update
February 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nephrology, University Clinical Center
Skopje, North Macedonia, 1000